Correspondence
Dermatitis induced by first-generation hepatitis C virus protease inhibitors
V. Descamps,
Corresponding Author
V. Descamps
Department of Dermatology, Bichat Claude Bernard Hospital, 46 rue Henri Huchard 75877, Paris Cedex 18, France
E-mail:
[email protected]Search for more papers by this author F. Fiszenson-Albala,
F. Fiszenson-Albala
Department of Dermatology, Bichat Claude Bernard Hospital, 46 rue Henri Huchard 75877, Paris Cedex 18, France
Search for more papers by this author
V. Descamps,
Corresponding Author
V. Descamps
Department of Dermatology, Bichat Claude Bernard Hospital, 46 rue Henri Huchard 75877, Paris Cedex 18, France
E-mail:
[email protected]Search for more papers by this author F. Fiszenson-Albala,
F. Fiszenson-Albala
Department of Dermatology, Bichat Claude Bernard Hospital, 46 rue Henri Huchard 75877, Paris Cedex 18, France
Search for more papers by this author
First published: 01 February 2015
No abstract is available for this article.
References
- 1Orrin E, Barnabas A, Agarwal K, Walsh SA. Cutaneous side-effects of antihepatitis C treatment: the U.K. experience. Br J Dermatol 2015; 172: 292–3.
- 2Roujeau JC, Mockenhaupt M, Tahan SR et al. Telaprevir-related dermatitis. Arch Dermatol 2013; 149: 152–8.
- 3Fiszenson-Albala F. Cutaneous disorders associated with hepatitis C virus. PhD Thesis, University of Marseille, 2003 (in French).
- 4Johnson CL, Owen DM, Gale M Jr. Functional and therapeutic analysis of hepatitis C virus NS3.4A protease control of antiviral immune defense. J Biol Chem 2007; 282: 10792–803.
- 5Binder M, Kochs G, Bartenschlager R, Lohmann V. Hepatitis C virus escape from the interferon regulatory factor 3 pathway by a passive and active evasion strategy. Hepatology 2007; 46: 1365–74.
- 6McHutchison JG, Manns MP, Muir AJ et al. Telaprevir for previously treated chronic HCV infection. N Engl J Med 2010; 362: 1292–303.
- 7Bacon BR, Gordon SC, Lawitz E et al. Boceprevir for previously treated chronic HCV genotype 1 infection. N Engl J Med 2011; 364: 1207–17.
- 8Lawitz E, Mangia A, Wyles D et al. Sofosbuvir for previously untreated chronic hepatitis C infection. N Engl J Med 2013; 368: 1878–87.
- 9Afdhal N, Reddy KR, Nelson DR et al. Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection. N Engl J Med 2014; 370: 1483–93.
- 10Afdhal N, Zeuzem S, Kwo P et al. Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection. N Engl J Med 2014; 370: 1889–98.
